Checkpoint Capital »

Flamel Technologies Sa shares owned by Checkpoint Capital

Quarter-by-quarter ownership of Flamel Technologies Sa (AVDL) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in Flamel Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Flamel Technologies Sa held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Flamel Technologies Sa by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 325k 14.12

More positions owned by Checkpoint Capital

Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Spdr Biotech Etf Tr Unit Put Option (XBI)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Mirum Pharmaceuticals (MIRM)
Protagonist Therapeutics (PTGX)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Phathom Pharmaceuticals (PHAT)
Atyr Pharma Com New (LIFE)
Trevi Therapeutics (TRVI)
Gh Research Ordinary Shares (GHRS)
Allakos (ALLK)

View all positions for Checkpoint Capital

Top funds holding Flamel Technologies Sa

Henderson Group
Jeffrey L. Gendell
Vivo Capital
Wealth Effects
Cowen And Company
Brandes Investment Partners
Tang Capital Management
Samsara BioCapital
Citadel Advisors
Tri Locum Partners
Balyasny Asset Management
Kennedy Capital Management
Knoll Capital Management
Modera Wealth Management
Goldman Sachs Group

View all funds holding Flamel Technologies Sa